CAS 51833-76-2

Angiotensin A

CAS: 51833-76-2

Bachem ID: 4055087.

Formula: C₄₉H₇₁N₁₃O₁₀

Purity: > 95%

Color and Shape: White Lyophilisate

Molecular weight: 1002.18

Ref: 01-4055087

H-Ala-Arg-Val-Tyr-Ile-His-Pro-Phe-OH

CAS: 51833-76-2

H-Ala-Arg-Val-Tyr-Ile-His-Pro-Phe (ARVIP) is a peptide with structural similarities to angiotensin II. The sequence of ARVIP is derived from the C terminus of angiotensinogen, which is cleaved by renin to form angiotensin I. ARVIP has been shown to produce vasoconstriction in experimental models of hypertension. In addition, ARVIP has been shown to have an inhibitory effect on the activity of angiotensin converting enzyme (ACE), which converts angiotensin I into angiotensin II. This inhibition leads to decreased production of vasoconstrictive substances and increased blood flow.
ARVIP also increases blood pressure through its ability to activate alpha 1 adrenergic receptors and stimulate release of norepinephrine from sympathetic nerve endings in the brain stem. It may also lead to an increase in coronary blood flow by

Formula: C₄₉H₇₁N₁₃O₁₀

Purity: Min. 95%

Molecular weight: 1,002.19 g/mol

Ref: 3D-PAN-3921-PI

Angiotensin A

CAS: 51833-76-2

Angiotensin A is a research tool that is used to study the activation of angiotensin receptors. It can be used to identify ligands and receptors and to investigate the pharmacology of peptides. Angiotensin A is soluble (1-2 mg/ml) in water, dimethyl sulfoxide (DMSO), and phosphate buffered saline. It has a CAS number of 51833-76-2.

Formula: C₄₉H₇₁N₁₃O₁₀

Purity: Min. 95%

Molecular weight: 1,002.2 g/mol

Ref: 3D-PAN-4474-V

Angiotensin A trifluoroacetate salt

CAS: 51833-76-2

Angiotensin A trifluoroacetate salt H-Ala-Arg-Val-Tyr-Ile-His-Pro-Phe-OH is a drug that has been shown to be effective in treating chronic kidney disease and heart failure. It is a synthetic peptide that mimics the activity of angiotensin II, an important regulator of blood pressure. Angiotensin A trifluoroacetate salt H-Ala-Arg-Val-Tyr-Ile-His-Pro-Phe-OH binds to the angiotensin receptor, which causes vasoconstriction and increases the release of soluble guanylate cyclase. This drug also inhibits the production of matrix metalloproteinases, which break down collagen and other extracellular proteins.

Formula: C₄₉H₇₁N₁₃O₁₀

Purity: Min. 95%

Molecular weight: 1,002.17 g/mol

Ref: 3D-FA109856